References
Hutt A.J., Caldwell J. (1983): The metabolic chiral inversion of 2-arylpropionic acids — a novel route with pharmacological consequences. J. Pharm. Pharmacol., 35, 693–704.
Ariens E.J. (1984): Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology. Eur. J. Clin. Pharmacol., 26. 663–668.
Nakamura Y., Yamaguchi T., Takahashi, S. Hashimoto, S., Iwatani W., Nakagawa Y. (1980): Optical isomerization mechanism of R(−)-hydratropic acid derivatives. Proceedings of 12th Symposium on Drug Metabolism & Action.
Wechter W.J., Loughheed D.G., Reischer R.J., Vangiessen G.J., Kaiser D.G. (1974): Enzymatic inversion at saturated carbon: nature and mechanism of the inversion of R(−)p-iso-butyl hydratropic acid. Biochem. Biophys. Res. Commun., 61, 833–837.
Williams K., Day R.. Knihinicki R., Duffield A. (1986): The stereoselective uptake of ibuprofen enantiomers into adipose tissue. Biochem. Pharmacol., 35, 3403–3405.
Caldwell J., Marsh M.V. (1983): Interrelationships between xenobiotic metabolism and lipid biosynthesis. Biochem. Pharmacol., 32, 1667–1672.
Kaiser D.G., Vangiessen G.J., Reischer R.J., Wechter W.J. (1976): Isomeric inversion of ibuprofen (R)-enantiomer in humans. J. Pharm. Sei., 65, 269–273.
Lee E.J.D., Williams K., Day R., Graham G., Champion D. (1985): Stereoselective disposition of ibuprofen enantiomers in man. Br. J. Clin. Pharmacol., 19, 669–674.
Jamali F., Singh N.N., Pasutto nF.M., Russell A.S., Coutts R.T. (dy1988): Pharmacokinetics of ibuprofen enantiomers in man following oral administration of tablets with different absorption rates. Pharm. Res., 5. In press.
Williams K.M., Day R.O. (1985): Stereoselective disposition — basis for variability in response to NSAIDs. In: Non-steroidal anti-inflammatory drugs basis for variability in response. Agents and actions Suppl., Birkhauser Verlag, Basel., pp. 119–127.
Cox S.R. (1987): Upjon Co., Kalamazoo MI, personal communication.
Mehvar R., Jamali F. (1978): Pharmacokinetic analysis of the enantiomeric inversion of chiral non-steroidal anti-inflammatory drugs. Pharm. Res. 5., In press.
Adams S.S., Bresloff P., Mason CG. (1976): Pharmacological differences between the optical isomers of ibuprofen: evidence for metabolic inversion of the (−)-isomer. J. Pharm. Pharmacol., 28,267–257.
Mills D.J., Adams S.S., Cliffe E.E., Dickinson W., Nicholson, J.S. (1973): The metabolism of ibuprofen. Xenobiotica 3, 589–598.
Cox J.W., Cox S.R., VanGiessen G., Ruwart M.J. (1985): Ibuprofen stereoisomer hepatic clearance and distribution in normal and fatty in situ perfused rat liver. J. Pharmacol. Exp. Ther., 232,636–643.
Rubin A., Knadler M.P., Ho P.P.K., Bechtol L.D., Wolen R.L. (1985): Stereoselective inversion of (R)-fenoprofen to (S)-fenoprofen in humans. J. Pharm. Sei., 74, 82–84.
MehvarR., Jamali F. (1988): Stereospecific HPLC assay of fenoprofen enantiomers in plasma and urine. Pharm. Res. 5, In press.
Hayball P.J., Meffin P.J. (1987): Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs. III. Fenoprofen disposition. J.Pharmacol Exp. Ther., 240,631–636.
Singh N.N., Jamali F., Pasutto F.M., Russell A.S., Coutts R.T., Drader K.S. (1986): Pharmacokinetics of the enantiomers of tiaprofenic acid in humans. J. Pharm. Sei., 75,439–442.
Wallis W.J., Simkin P.A. (1983): Antirhematic drug concentrations in human synovial fluid and synovial tissue. Observations on extravascular pharmacokinetics. Clin. Pharmacokin., 8, 496–522.
Jamali F., Mehvar R., Russell A.S. (dy1978): Pharmacokinetics of tiaprofenic acid enantiomers in renal dysfunction. Jap. US. Cong. Pharm. Sci. December 2–7, Honolulu, Hawaii.
Foster R.T., Jamali F., Russell A.S., Alballa S.R. (1987): Pharmacokinetics of ketoprofen enantiomers in healthy subjects following single and multiple doses. J. Pharm. Sei., In press.
Foster R.T., Jamali F., Russell A.S., Alballa S.R. (1987): Pharmacokinetics of ketoprofen enantiomers in young and elderly arthritic patients following single and multiple doses. J. Pharm. Sei., Submitted.
Advenier C, Roux A, Gobert C, Massias P., Varoquax 0., Flouvat B. (1983): Pharmacokinetics of ketoprofen in the elderly. Br. J. Clin. Pharmacol., 16, 65–70.
Stafanger G., larsen H.W., Hansen H., Sorensen K. (1981): Pharmacokinetics of ketoprofen in patients with chronic renal failure. Scand. J. Rheumatol., 10, 189–192.
Foster R.T., Jamali F. (1987): Stereoselective pharmacokinetics of ketoprofen in the rat: influence of route of administration. Pharm. Res. 4, S-117.
Abas A., Meffin P.J. (1987): Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs. IV. Ketoprofen kisposition. J. Pharmacol. Exp. Ther., 240, 637–641.
Jamali F., Berry B.W., Tehrani M.R., Russell A.S. (1987): Stereoselective pharmacokinetics of flurbiprofen in man and rat. J. Pharm. Sei., Submitted.
Tamassia V., Jannuzzo M.G., Moro E., Stegnjaich S., Groppi W., Nicolis F.B. (1984): Pharmacokinetics of the enantiomers of indoprofen in man. Int. J. Clin. Pharmacol. Res., 4, 223–230.
Bjorkman S. (1985): Stereoselective disposition of indoprofen in surgical patients. Br. J. Clin. Pharmacol., 20,463–467.
Buttinoni A., Ferrari M., Colombo M.. Ceserani R. (1983): Biological activity of indoprofen and its optical isomers. J. Pharm. Pharmacol. 35,603–604.
Kemmerer J.M., Rubio F.A., McClain R.M.. Koechlin B.A. (1979): Stereospecific assay and stereospecific disposition of racemic carprofen in rats. J. Pharm. Sei., 68, 1274–1280.
Stoltenborg J.K., Puglisi C.V., Rubio F., Vane F.M. (1981): High-performance liquid chromatographic determination of stereoselective disposition of carprofen in humans. J. Pharm. Sei., 70, 1207–1212.
Lee Y.C., Gee W.L., Benet L.Z., Lin E.T. (1986): Stereoselective analysis of carprofen in plasma by HPLC using precolumn derivatization. Pharm. Res. 3, 7S.
Spahn H., Benet l.Z. (1987): Changes in the disposition of carprofen enantiomers caused by probenecid. Arch. Pharmacol. 335 (Supp), R7.
Simmonds R.G., Woodage T.J., Duff S.M., Green J.N. (1980): Stereospecific inversion of (R)-(−)-benoxaprofen in rat and man. Eur. J. Drug Metab. Pharmacokin., 5, 169–172.
Sioufi A., Colussi D., Marfil F., Dubois J.P. (1987): Determination of the (+)- and (−)-enantiomers of pirprofen in human plasma by high-performance liquid chromatography. J. Chromatogr., 414, 131–137.
Goto J., Goto N. Nambara T. (1982): Separation and determination of naproxen enantiomers in serum by high-performance liquid chromatography. J. Chromatogr., 239, 539–564.
Kripalani K.J., Zein El-Abdin, A., Dean A.V., Schreiber E.C. (1976): Stereospecifc inversion of l-CX-methylfluorene-2-acetic acid of its d-enantiomer in the dog. Xenobiotica, 6, 159–169.
Lan S.J., Kripalani K.J., Dean A.V., Egli P., Difazio L.T., Schreiber E.C. (1976): Inversion of optical configuration of 1-(α-methylfluorene-2-acetic acid (cicloprofen) in rats and monkeys. Drug Metab. Dispos., 4, 330–339.
Tamura S., Kuzuna S., Kawai K. (1981): Inhibition of prostaglandin biosynthesis by clindanac and related compounds: structural and conformational requirements for PG synthetase inhibition. J. Pharm. Pharmacol., 33, 29–32.
Tamura S., Kuzuna S., Kawai K., Kishimoto S. (1981): Optical isomerization of R(−)-clindanac to the biologically active S(+)−isomer in guinea-pigs. J. Pharm. Pharmacol., 33,701–706.
Nagashima H., Tanaka Y., Watanabe H., Hayashi R., Kawada K. (1984): Optical inversion of (2R)- to (2S)-isomers of 2-[4-(2-oxocyclopentylmefhyl)-phenyll-propionic acid (loxoprofen), a new anti-inflammatory agent, and its monohydroxy metabolttes in the rat. Chem. Pharm. Bull., 32, 251 -257.
Nagashima H., Tanaka Y., Hayashi R. (1985): Column liquid chromatography for the simultaneous determination of the enantiomers of loxoprofen sodium and its metabolites in human urine. J. Chromatogr., 345, 373–379.
Humber L.G., Demerson C.A., Swaminathan P., Bird P.H. (1986): Etodolac (l,8-dimethyl-l,3,4,9-tetrahydro-pyrano[3,4-bjindol-l-acetic acid): a potent anti-inflammatory drug. Conformation and absolute configuration of its active enantiomer. J. Med. Chem. 29, 871–874.
Singh N.N., Jamali F., Pasutto F.M., Coutts R.T. (1986): Stereoselective gas chromatographic analysis of etodolac enantiomers in human plasma and urine. J. Chromatogr., 312, 331–337.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jamali, F. Pharmacokinetics of enantiomers of chiral non-steroidal anti-inflammatory drugs. European Journal of Drug Metabolism and Pharmacokinetics 13, 1–9 (1988). https://doi.org/10.1007/BF03189920
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03189920